I agree. Someone pointed out to me that they need the money to finish up multiple big trials, but they choose to do ATM instead of a new offering, which is very bullish. With ATM it means 1. it's optional depending on the market price, and 2. they sell at the market price to all investors at the time they choose (versus a discounted price to hedge funds) , which is more shareholder friendly, and 3. this means buyouts is Not off the table. And $1b is only 4-5% dilution.